Analysed Takeda Pharmaceutical Co Ltd (TAK:NYSE) News Sources
Which Is a Better Investment, Nektar Therapeutics or Phibro Animal Health Corporation Stock?
American Association of Individual Investors
US FDA accepts Takeda and Protagonist’s NDA and grants priority review status for rusfertide as a potential first-in-class therapy for polycythaemia vera
Pharmabiz
HUTCHMED (China) Limited: HUTCHMED Reports 2025 Full Year Results and Business Updates
FinanzNachrichten.de
Faron and City of Hope in Process of Developing a Phase II Investigator-Initiated Trial of Bexmarilimab in Relapsed/Refractory MDS
Le Lézard
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
Markets Insider
What is the current price of Takeda Pharmaceutical Co Ltd (TAK:NYSE)?
The current price of Takeda Pharmaceutical Co Ltd (TAK:NYSE) is $17.88.
Takeda Pharmaceutical Co Ltd (TAK:NYSE) absolute price change since previous trading day?
The absolute price change of Takeda Pharmaceutical Co Ltd (TAK:NYSE) since the previous trading day is $0.13.
Takeda Pharmaceutical Co Ltd (TAK:NYSE) percentage price change since previous trading day?
The percentage price change of Takeda Pharmaceutical Co Ltd (TAK:NYSE) since the previous trading day is 0.73%.
What is This Week's average sentiment score for Takeda Pharmaceutical Co Ltd (TAK:NYSE)?
This Week's average sentiment score for Takeda Pharmaceutical Co Ltd (TAK:NYSE) is 69 out of 100.
What is This Week's average sentiment for Takeda Pharmaceutical Co Ltd (TAK:NYSE)?
This Week's sentiment for Takeda Pharmaceutical Co Ltd (TAK:NYSE) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.